LRP1B and familial pancreatic carcinoma: Several observations favor LRP1B being a bona fide driver mutation in many tumors, including a very high frequency of homozygous deletions (42), and frequent point mutation in esophagus (18), oral (20), liver (43), colon (44), gastric (21), breast (45), thyroid (46), and pancreatic cancer (47).